Twitter Beğeni Hilesi

🚀 Dive into the world of bioprocessing and pre-clinical translation with Work Package 7 of the MAGIC Project, led by DNMQS. Work includes the fabrication of validated muscle-on-chip devices and developing AAVs & LVVs batches using GMP-compatible processes.magic-horizon.eu/about/objectiv…

Receive regular updates on accelerating the development of genetic therapies for muscular dystrophies. Sign up for the MAGIC newsletter and receive regular progress updates, in your inbox. eepurl.com/iCC9E2

We are excited to have Prof. Saverio Tedesco present at #ASGCT2024 in Baltimore, USA 📣 Engineering human skeletal muscle for advanced modeling of neuromuscular diseases and therapeutics 🕓 4:11PM-4:37PM EST Join Francesco Saverio Tedesco to explore this topic in neuromuscular research!

Unite with MAGIC in pioneering gene therapies, shaping precision medicine & redefining healthcare for neuromuscular disorders. Explore collaborations opportunities in organ-on-chip, gene therapy process development & manufacturing and more For more see: magic-horizon.eu

Curious how MAGIC will achieve the ambitious goal of creating next-gen gene therapies for rare neuromuscular diseases? Have a look at the workplan: magic-horizon.eu/about/workplan/

The goal of MAGIC is to develop precise gene therapies using cutting-edge technologies, such as muscle-on-chip devices, focusing on muscular dystrophies. Read more: magic-horizon.eu/about/objectiv…

We’re hiring! Please visit our website for more info on the 2 openings. Hurry up: deadline on 11 June 2024! tedescolab.org/vacancies

We are proud to announce that iMM (iMM) joins the MAGIC Consortium to advance research on muscular dystrophies. With iMM's expertise, MAGIC will enhance muscle-on-chip models and develop new genetic therapies. 🤝 Welcome on board! Learn more: magic-horizon.eu/news/imm-joins…

🔬🧬New publication! Researchers have developed an affordable and easy-to-use method for creating custom cell culture devices with 3D printing and soft lithography. This will allow biology labs to design tools tailored to their unique experiments. doi.org/10.1371/journa…

MAGIC aims to pioneer in gene therapies for effective treatment. Our approach involves close collaboration with patient advocacy groups, ensuring a patient-centric focus. Learn more about our groundbreaking advancements: magic-horizon.eu/about/objectiv…

📖Check out the first publication from the MAGIC project by Hagemann C et al. on 'Low-cost, versatile, and highly reproducible microfabrication pipeline to generate 3D-printed customised cell culture devices with complex designs'. Read more: magic-horizon.eu/news/lay-summa…

👩‍⚕️ A message to clinicians: Stay informed on the latest advancements in muscular dystrophy treatments. Subscribe to the MAGIC newsletter for exclusive updates and clinical insights. Sign up: eepurl.com/iCC9E2

🌟 Exciting News from the MAGIC Project! 🌟 Prof. Francesco Saverio Tedesco presented the innovative approaches of the MAGIC Project at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting in Baltimore, USA (May 7-11 2024). More here: magic-horizon.eu/news/prof-save…

🧬MAGIC aims to revolutionise gene therapies with specialised muscle-on-chip devices, providing precise assessments for novel treatments. 🌐Explore the future of neuromuscular disorder research with us: magic-horizon.eu/about/objectiv…

🔎 The MAGIC Mission is to accelerate genetic therapy development through advanced models, aiming to overcome barriers and impact the lives of people with muscular dystrophy. Interested to find out more? Check out magic-horizon.eu

🔬One of the goals of MAGIC is to create precise models for gene therapies in rare neuromuscular conditions. Take a look at the full workplan: magic-horizon.eu/about/workplan/

🔍 Curious how the MAGIC project operates? Delve into the work plan, detailing tasks and responsibilities across work packages. Explore our roadmap to revolutionise gene therapies for rare neuromuscular disorders: magic-horizon.eu/about/workplan/

📣 Receive regular updates on accelerating the development of genetic therapies for muscular dystrophies. Sign up for the MAGIC newsletter and receive regular progress updates, in your inbox. eepurl.com/iCC9E2

📣 Yesterday, Ilaria Zito from Parent Project aps Italy presented the MAGIC project at the Interuniversity Institute of Myology Meeting in Assisi. 🤝 Here, she emphasized the importance of patient associations in bridging science and families and guiding research on Duchenne and Becker muscular dystrophy.

🎙️ We spoke with Marie Fertin, Chief Technological Innovation Officer at VIVEbiotech. She shared insights into their role as a specialized CDMO in lentiviral vectors and their contribution to MAGIC's ambitious goals. Read the full interview here: shorturl.at/fhVq7